Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-012758
Filing Date
2021-05-24
Accepted
2021-05-24 17:27:01
Documents
45
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 787768
2 ex31-1.htm EX-31.1 18741
3 ex32-1.htm EX-32.1 8549
  Complete submission text file 0001493152-21-012758.txt   3932723

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atrx-20210331.xsd EX-101.SCH 30199
5 XBRL CALCULATION FILE atrx-20210331_cal.xml EX-101.CAL 29330
6 XBRL DEFINITION FILE atrx-20210331_def.xml EX-101.DEF 152283
7 XBRL LABEL FILE atrx-20210331_lab.xml EX-101.LAB 266238
8 XBRL PRESENTATION FILE atrx-20210331_pre.xml EX-101.PRE 208641
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 541022
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

EIN.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 21956297
SIC: 2834 Pharmaceutical Preparations